Biotest AG Cash Flow Statement

BIO3 €30.1 -0.1 -0.3%

25/02/21

Conservative, Mid Cap, Momentum Trap

Market Cap £1.03bn

Enterprise Value £1.38bn

Revenue £404.7m

Quality

Value

Momentum

StockRank™

To unlock Biotest AG's cashflow statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	EUR	EUR	EUR	EUR	EUR	EUR

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Discontinued Operations
Unusual Items
Equity in Net Earnings (Loss)
Other Non-Cash Items
Changes in Working Capital
Other Assets
Accounts Payable
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Investment, Net
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Total Cash Dividends Paid
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.